Wellington Management Group LLP Has $16.10 Million Stake in The Cooper Companies, Inc. (NASDAQ:COO)

Wellington Management Group LLP boosted its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 517.1% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 175,152 shares of the medical device company’s stock after buying an additional 146,771 shares during the quarter. Wellington Management Group LLP’s holdings in Cooper Companies were worth $16,102,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in the stock. O Shaughnessy Asset Management LLC boosted its holdings in Cooper Companies by 28.8% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 7,487 shares of the medical device company’s stock valued at $688,000 after acquiring an additional 1,675 shares during the last quarter. CIBC Private Wealth Group LLC lifted its position in shares of Cooper Companies by 27.9% in the 4th quarter. CIBC Private Wealth Group LLC now owns 25,627 shares of the medical device company’s stock worth $2,355,000 after purchasing an additional 5,589 shares during the period. Schroder Investment Management Group boosted its stake in shares of Cooper Companies by 6.8% in the 4th quarter. Schroder Investment Management Group now owns 629,076 shares of the medical device company’s stock valued at $57,516,000 after purchasing an additional 40,231 shares during the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Cooper Companies by 280.5% during the fourth quarter. Arrowstreet Capital Limited Partnership now owns 255,718 shares of the medical device company’s stock worth $23,508,000 after buying an additional 188,513 shares during the period. Finally, Allianz SE bought a new position in Cooper Companies during the fourth quarter worth $128,000. Institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

COO has been the topic of a number of research analyst reports. BNP Paribas raised shares of Cooper Companies to a “hold” rating in a research report on Thursday, March 13th. Citigroup cut their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Friday, March 7th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a report on Friday, March 7th. Robert W. Baird cut their price target on Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Finally, StockNews.com downgraded shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Four investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus target price of $110.25.

Cooper Companies Price Performance

Shares of COO opened at $71.50 on Wednesday. The business’s fifty day moving average is $86.17 and its 200 day moving average is $95.43. The Cooper Companies, Inc. has a 12-month low of $70.45 and a 12-month high of $112.38. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The stock has a market cap of $14.30 billion, a P/E ratio of 36.67, a P/E/G ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm had revenue of $964.70 million during the quarter, compared to analysts’ expectations of $981.25 million. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.